Iovance Biotherapeutics Inc (NASDAQ: IOVA) kicked off on Monday, up 5.00% from the previous trading day, before settling in for the closing price of $2.2. Over the past 52 weeks, IOVA has traded in a range of $1.64-$9.30.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 4.17%. While this was happening, its average annual earnings per share was recorded 15.83%. With a float of $333.00 million, this company’s outstanding shares have now reached $385.46 million.
Iovance Biotherapeutics Inc (IOVA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Iovance Biotherapeutics Inc is 16.12%, while institutional ownership is 47.09%. The most recent insider transaction that took place on Jun 05 ’25, was worth 55,200. In this transaction Chief Commercial Officer of this company bought 30,000 shares at a rate of $1.84, taking the stock ownership to the 30,000 shares. Before that another transaction happened on May 23 ’25, when Company’s Chief Regulatory Officer bought 5,600 for $1.74, making the entire transaction worth $9,743. This insider now owns 206,852 shares in total.
Iovance Biotherapeutics Inc (IOVA) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.26 earnings per share (EPS), higher than consensus estimate (set at -0.27) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.64% during the next five years compared to 4.17% growth over the previous five years of trading.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Trading Performance Indicators
Take a look at Iovance Biotherapeutics Inc’s (IOVA) current performance indicators. Last quarter, stock had a quick ratio of 3.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.20, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of Iovance Biotherapeutics Inc (IOVA)
Compared to the last year’s volume of 13.63 million, its volume of 9.01 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 28.32%.
During the past 100 days, Iovance Biotherapeutics Inc’s (IOVA) raw stochastic average was set at 21.40%, which indicates a significant decrease from 41.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.16 in the past 14 days, which was lower than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.24, while its 200-day Moving Average is $2.58. Nevertheless, the first resistance level for the watch stands at $2.38 in the near term. At $2.45, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.56. If the price goes on to break the first support level at $2.20, it is likely to go to the next support level at $2.09. Now, if the price goes above the second support level, the third support stands at $2.02.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Key Stats
The company with the Market Capitalisation of 917.00 million has total of 396,968K Shares Outstanding. Its annual sales at the moment are 164,070 K in contrast with the sum of -372,180 K annual income. Company’s last quarter sales were recorded 67,460 K and last quarter income was -91,250 K.
